Showing results (1341-1350 of 1,668) with videos related to
Sort By:
Pageof 167
Archives of Andrology|September 8, 1998
Multicenter study on reproducibility of sperm morphology assessmentsW Ombelet, E Bosmans, M Janssen, et al.Biotechnology and Bioengineering|September 5, 2002
Integrated reactor concepts for the enzymatic kinetic synthesis of cephalexinC G P H Schroën, V A Nierstrasz, R Bosma, et al.Nature Communications|January 18, 2019
Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in miceRaffaella Rossin, Ron M Versteegen, Jeremy Wu, et al.Acta Biomaterialia|August 29, 2015
Hydrolytic and oxidative degradation of electrospun supramolecular biomaterials: In vitro degradation pathwaysM C P Brugmans, S H M Sӧntjens, M A J Cox, et al.Diabetologia|September 29, 2006
Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in miceE Korsheninnikova, G C M van der Zon, P J Voshol, et al.Physical & Occupational Therapy in Pediatrics|February 29, 2020
Reliability and Responsiveness of the Observable Movement Quality Scale for Children with Mild to Moderate Motor ImpairmentsLieke M A Dekkers, Bert J M de Swart, Marianne Jonker, et al.Journal of Neuroscience Methods|April 4, 2007
Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brainSonia Franciosi, Rita De Gasperi, Dara L Dickstein, et al.Journal of Hepatology|January 27, 2016
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acidNoortje Ijssennagger, Aafke W F Janssen, Alexandra Milona, et al.Nature Communications|May 6, 2018
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in miceRaffaella Rossin, Ron M Versteegen, Jeremy Wu, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|January 19, 2025
PTV Margins in MR-guided and Beam-gated SBRT of Liver Metastases: GTV Dose Escalation Can Reduce the Required PTVI Wahlstedt, E van der Bijl, K Boye, et al.Pageof 167